Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells

Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells

Abstract Background Autologous cellular immunotherapy or immune enhancement therapy has demonstrated some promising benefits for prostate cancer. T cell-based immunotherapy or sipuleucel-T therapy has yielded certain beneficial responses and a slight improvement on the overall survival of patients w...

Full description

Bibliographic Details
Main Authors: Zhu Wang, Youjia Li, Yuliang Wang, Dinglan Wu, Alaster Hang Yung Lau, Pan Zhao, Chang Zou, Yong Dai, Franky Leung Chan
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Stem Cell Research & Therapy
Subjects:
Prostate cancer stem-like cells
Dendritic cells
Cytokine-induced killer cells
Cellular immunotherapy
Cell membrane antigen
Online Access:http://link.springer.com/article/10.1186/s13287-020-01634-6

Internet

http://link.springer.com/article/10.1186/s13287-020-01634-6

Similar Items